These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24742492)

  • 1. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
    D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
    Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
    Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
    Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of legumain and cystatin 6 expression at the maternal-fetal interface in pigs.
    Shim J; Seo H; Choi Y; Yoo I; Lee CK; Hyun SH; Lee E; Ka H
    Mol Reprod Dev; 2013 Jul; 80(7):570-80. PubMed ID: 23686917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
    Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
    Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea.
    Zeeuwen PL; van Vlijmen-Willems IM; Cheng T; Rodijk-Olthuis D; Hitomi K; Hara-Nishimura I; John S; Smyth N; Reinheckel T; Hendriks WJ; Schalkwijk J
    FASEB J; 2010 Oct; 24(10):3744-55. PubMed ID: 20495178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer.
    Pulukuri SM; Gorantla B; Knost JA; Rao JS
    Oncogene; 2009 Aug; 28(31):2829-38. PubMed ID: 19503093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis.
    Jin L; Zhang Y; Li H; Yao L; Fu D; Yao X; Xu LX; Hu X; Hu G
    Cell Res; 2012 Sep; 22(9):1356-73. PubMed ID: 22688893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
    McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
    Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.
    Li X; Liang Y; Lian C; Peng F; Xiao Y; He Y; Ma C; Wang Y; Zhang P; Deng Y; Su Y; Luo C; Kong X; Yang Q; Liu T; Hu G
    Theranostics; 2021; 11(20):9821-9832. PubMed ID: 34815788
    [No Abstract]   [Full Text] [Related]  

  • 10. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth.
    Hosokawa M; Kashiwaya K; Eguchi H; Ohigashi H; Ishikawa O; Furihata M; Shinomura Y; Imai K; Nakamura Y; Nakagawa H
    Cancer Sci; 2008 Aug; 99(8):1626-32. PubMed ID: 18754876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
    Wallin H; Apelqvist J; Andersson F; Ekström U; Abrahamson M
    J Biol Chem; 2017 Sep; 292(35):14413-14424. PubMed ID: 28630039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoplasmic calcium regulates cell proliferation through legumain.
    Andrade V; Guerra M; Jardim C; Melo F; Silva W; Ortega JM; Robert M; Nathanson MH; Leite F
    J Hepatol; 2011 Sep; 55(3):626-635. PubMed ID: 21237226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss-of-function mutations in CST6 cause dry skin, desquamation and abnormal keratosis without hypotrichosis.
    Wang X; Liu J; Chen J; Xu X; Zhong Y; Xu Y; Lu P; Zhou J; Lin Z; Yang B; Yang C
    Clin Genet; 2023 Mar; 103(3):301-309. PubMed ID: 36371786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
    Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Targeting Legumain for Inhibiting Cancers.
    Reddy BD; Beeraka NM; Chitturi CMK; Madhunapantula SV
    Curr Pharm Des; 2021 Oct; 27(31):3337-3348. PubMed ID: 33238867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of silencing the T‑Box transcription factor TBX2 in prostate cancer PC3 and LNCaP cells.
    Du WL; Fang Q; Chen Y; Teng JW; Xiao YS; Xie P; Jin B; Wang JQ
    Mol Med Rep; 2017 Nov; 16(5):6050-6058. PubMed ID: 28849151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
    Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
    J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
    Wang B; Lindley LE; Fernandez-Vega V; Rieger ME; Sims AH; Briegel KJ
    PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
    Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
    Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
    Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
    Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.